1. Introduction {#s0005}
===============

Diseases caused by intestinal parasites are one of the main public health problems around the world ([@bb0040]). These infections are frequent in children from developing countries, who often live in rural and indigenous communities ([@bb0080]; [@bb0220]). Usually, transmission of these enteropathogens is linked to environmental contamination with human/animal feces, directly via hand-mouth or indirectly through ingestion of contaminated food or water ([@bb0295]; [@bb0085]; [@bb0125]).

*Blastocystis* sp. is considered the most prevalent intestinal human protozoan in the world ([@bb0060]). There are many unknown characteristics of organism ([@bb0245]; [@bb0130]), and whether it is pathogenic or not is controversial ([@bb0260]; [@bb0210]). Consequently, there are debates over the need to treat infected people ([@bb0050]; [@bb0020]; [@bb0260]). The prevalence of this infection varies from one country to another, according to diagnostic methodology used and hygienic-sanitary conditions, exceeding 5% in industrialized countries and reaching 30--100% in poor countries ([@bb0060]). Although there are factors that favor its transmission, such as lack of hygiene, consumption of contaminated food and zoonotic contact, other specific conditions of particular epidemiological scenarios must be considered ([@bb0160]; [@bb0025]; [@bb0215]; [@bb0030]; [@bb0115]).

*Blastocystis* sp., like other potentially pathogenic protozoa, presents a high genetic diversity, and a significant number of subtypes (ST) have been described ([@bb0235]; [@bb0030]; [@bb0290]), all of them with similar morphological characteristics. Ten of the described subtypes (ST1-ST9, ST12) have been reported in humans, while the subtypes ST10, ST11, ST13-ST17 have been found only in non-human hosts ([@bb0250]; [@bb0245]; [@bb0200]; [@bb0060]). The geographical distribution of subtypes and the distribution of patients with potential symptoms associated with this infection ([@bb0205]) are not homogeneous in North and South America ([@bb0120]). In this sense, it is important to characterize each epidemiological scenario before developing surveillance, prevention and control measures. In this same line, the genetic diversity of *Blastocystis* sp. has only been partially studied in Latin America; studies in Colombia, Brazil, Argentina and Mexico have shown that humans are infected primarily with ST1-ST3 ([@bb0200]; [@bb0215]). There are few investigations on the prevalence *Blastocystis* sp. in Panama ([@bb0225]), and, to our knowledge, there is no prior genetic typing study of this parasite in Panama. The objective of this cross-sectional study was to evaluate the prevalence, subtypes, and epidemiological factors related to infection with *Blastocystis* sp. in children from of a small rural community in the central area of the isthmus of Panamá.

2. Methods {#s0010}
==========

2.1. Study area {#s0015}
---------------

A descriptive and cross-sectional study was conducted during the months of July and August 2017 in a rural community called Las Pavas (9°6′15″N, 79°53′9″W), located in the district of La Chorrera, province of Panamá Oeste, 80 km from the city of Panama ([Fig. 1](#f0005){ref-type="fig"}). It is a settlement of approximately 99 homes, 50--150 m above sea level, located on the west shore of the Panama Canal. The community is surrounded by pastures and some remnant forest patches. The climate of the region is considered humid tropical lowland, with an annual average temperature of 26 °C and an average annual precipitation of 2500 mm. Most homes are supplied with non-chlorinated water through a local aqueduct, however the use water from other sources (wells, streams, rain etc.) is common. A dairy and horse breeding farm is located practically in the middle of the town, close to the underground water source for the aqueduct and to the primary school. Much of the population is engaged in agricultural activities, raising domestic animals, and working on private nearby farms.Fig. 1Geographic location of the community of Las Pavas, Province of Panama Oeste, where children\'s stool samples were collected.Fig. 1

2.2. Study population, sample collection and questionnaire analysis {#s0020}
-------------------------------------------------------------------

All students (94) from the only primary school in the community were invited to participate in the study. After presenting a basic talk and graphic material about intestinal parasitic diseases, each student was given a plastic container with a lid. The safe way to perform feces collection was explained to them, and these instructions were also sent in graphic and written forms to the parents. Recently collected fecal samples were brought to the school two days after the fecal collection instructions. Every house in the community where children live was also visited to carry out a questionnaire with the help of their parents. Information concerning age, sex, clinical symptoms, defecation habits, hygiene customs, water sources, presence of animals and dwelling characteristics were collected. Informed consent, approved by the Research Bioethics Committee of the Gorgas Memorial Institute (1028/CBI/ICGES/07), was obtained from all parents or legal guardians of minors. The study was designed as a cross-sectional study, and the results were analyzed using descriptive statistics to determine the frequency of *Blastocystis* sp. infection. Fisher\'s exact test or Chi-square were conducted to evaluate possible associations between *Blastocystis* sp. presence and each of the 13 variables collected during the survey ([Fig. 2](#f0010){ref-type="fig"}). A level of *p* \< 0.05 was considered to be a statistically significant association. All statistical analyses were performed using the open source software OpenEpi (<http://www.openepi.com/Menu/OE_Menu.htm>).Fig. 2Descriptive and statistical analysis of possible rick factors for *Blastocystis* sp. infection among children from the community of Las Pavas, Province of Panama Oeste. Gender/age (A) and recent diarrhea data (B) refer to the 66 evaluated children. The rest of the information were obtained from the survey conducted in 37 houses: having received an anti-intestinal parasites treatment during the last 2 months (B), number of people living in the house (C), parent\'s formal education (D), water source (E), floor construction materials (E), sanitary facilities (E), contact with domestic animals (E), contact with soil (E) and frequency of hand washing (E). *p values* were determined by the Fisher exact test or by chi-square test (age groups). Statically significant association are marked with an asterisk (\*), *p* \< 0.05.Fig. 2

2.3. Frequency and genetic characterization of *Blastocystis* sp. {#s0025}
-----------------------------------------------------------------

At the time of collection, fresh samples were divided each into two portions. The first portion was frozen at −20 °C without any additives in a small plastic container. The second portion was stored with 5% formalin solution in preparation for fecal parasite concentration processing. Within a week of collection, the 66 preserved samples were processed by means of a formalin ethyl acetate sedimentation procedure ([@bb0100]). DNA was extracted with QIAmp DNA Stool Minikit (Qiagen Inc., Germantown, MD) from 200 mg of each frozen stool sample, according to the manufacturer\'s instructions.

For each sample, 5 μl of extracted DNA was subjected to PCR assay using the *Blastocystis* sp. specific primers BL18SPPF1 (5′-AGTAGTCATACGCTCGTCTCAAA-3′) and BL18SR2PP (5′-TCTTCGTT ACCCGTTACTGC-3′) ([@bb0195]). These primers target a DNA fragment of 320 to 342 bp of the *Blastocystis* sp. SSU rDNA gene, depending on the ST. The amplified products were purified and directly sequenced on both strands by Sanger sequencing using BigDye™ Terminator v3.1 Cycle Sequencing Kit following manufacturer\'s instructions. The capillary electrophoresis of the sequencing fragments was performed in the ICGES-Panama sequencing facilities using an ABI 3500xL sequencer.

All electrophorograms were trimmed and edited using the Sequencher 4.1.4 software (Gene Codes Corp., Ann Arbor, Michigan). The FASTA results, along with the reference sequences obtained in the GenBank were then aligned using the program MAFFT under the bioinformatic package UGENE v1 31.1 ([@bb0175]) that was set up with a gap opening penalty of 2.03, an offset configuration of 2.00 and a maximum number of iterative refinements of 20. The acquired sequences were used for a gene homology search, with the SSU rDNA sequences accessible in the public databases from BLAST (NCBI, Bethesda, MD, USA).

2.4. Ethical considerations {#s0030}
---------------------------

The study was approved by the Research Bioethics Committee of the Gorgas Memorial Institute (1028/CBI/ICGES/07). All the information generated was of strict confidentiality and it was guaranteed that it was used only to comply with the objectives of the study.

3. Results {#s0035}
==========

3.1. Frequency and genetic characterization of *Blastocystis* sp*.* {#s0040}
-------------------------------------------------------------------

A total of 66 fecal samples were collected. Microscopic analysis revealed that 33.3% (22/66) of the analyzed samples had enteroparasites. Among the parasites found by microscopy, *Blastocystis* sp. was the most prevalent with 21.2% (14/66), followed by the *E. histolytica/dispar/moshkovskii* complex 4.5% (3/66), *Giardia lamblia* 1.5% (1/66) and *Strongyloides stercoralis* 1.5% (1/66). Only five samples had more than one species of intestinal parasite ([Table 1](#t0005){ref-type="table"}). Further PCR-based analyses detected a prevalence of *Blastocystis* sp. infection of 74.2% (49/66) in apparently healthy children ([Table 1](#t0005){ref-type="table"}). All 49 *Blastocystis* sp. positive samples confirmed by PCR were successfully subtyped by the SSU rDNA gene. BLAST search and phylogenetic analysis identified two subtypes, ST1 with 42.2% (28/66) and ST3 with 31.8% (21/66). No mixed infections were found with these two subtypes. The 49 *Blastocystis* SSU rDNA sequences were deposited in Gene Bank-NCBI 330 under accession numbers: MN503605-MN503653.Table 1Frequency of intestinal parasites infections among children from the community of Las Pavas, Province of Panama Oeste, Panama.Table 1No. of positive samples (%)*Blastocystis* sp.14 (21.2)[a](#tf0005){ref-type="table-fn"}*Blastocystis* sp.49 (74.2)[b](#tf0010){ref-type="table-fn"}*Blastocystis* sp. *-E. histolytica/dispar/moshkovskii* complex2 (3.0)[a](#tf0005){ref-type="table-fn"}*Blastocystis* sp. *- Giardia lamblia*1 (1.5)[a](#tf0005){ref-type="table-fn"}*Blastocystis* sp. *- Strongyloides stercoralis*1 (1.5)[a](#tf0005){ref-type="table-fn"}*E. histolytica/dispar/moshkovskii* complex3 (4.5)[a](#tf0005){ref-type="table-fn"}*Giardia lamblia*1 (1.5)[a](#tf0005){ref-type="table-fn"}[^1][^2]

3.2. Questionnaire survey {#s0045}
-------------------------

Descriptive and statistical analysis of possible risk factors for *Blastocystis* sp. infection are shown in [Fig. 2](#f0010){ref-type="fig"}. Of the 66 stool samples analyzed, 46.9% (31/66) were male and 53.0% (35/66) were female. Infection with *Blastocystis* sp. was similar in both genders (24 boys and 25 girls). The registered age range was 1--12 years, including 14 children who still did not attend school. None of the assigned age ranges were significantly associated with *Blastocystis* sp. infection. Significant associations were found between *Blastocystis* sp. infection and children who had experienced diarrhea events 1--4 weeks before the coprological evaluation (*p* \< 0.05) ([Fig. 2](#f0010){ref-type="fig"}B). None of the other variables evaluated showed a significant relationship with in *Blastocystis* sp. infection. These variables were: water source (rural aqueduct, non-chlorinated), floor construction materials, sanitary facilities, contact with domestic animals, contact with soil, frequency of hand washing, having received an anti-intestinal parasites treatment during the last 2 months, family size, and parent\'s formal education ([Fig. 2](#f0010){ref-type="fig"}).

4. Discussion {#s0050}
=============

Human infection with *Blastocystis* sp. occurs both in urban and rural areas worldwide, often affecting children ([@bb0165]). Despite being very frequent and with potential pathogenicity, this organism is mainly characterized by nonspecific gastrointestinal symptoms ([@bb0305]). In rural environments, there are proposed factors that can favor the transmission of *Blastocystis* sp., such as lack of hygiene, consumption of contaminated food, and zoonotic contact ([@bb0215]; [@bb0270]; [@bb0030]). Several studies have suggested that this infection may be a consequence of food intake or water contaminated with feces of domestic animals ([@bb0025]; [@bb0140]; [@bb0135]). The high prevalence found for this infection in children from a rural community in Panama should be called to the attention of medical services due to the risk of illness and possible linkages with poor sanitary conditions or particular ecological conditions. In addition, as *Blastocystis* sp. is an organism with a proven genetic diversity ([@bb0235]), it is also important to identify which genetic variants infect these children and the related epidemiological factors.

In this study, microscopic analysis showed that 33.3% (22/66) of the children were infected with some intestinal parasite. *Blastocystis* sp. accounted for 63.6% (14/22) of these positive samples. However, after SSU rDNA-PCR analysis, 35 additional samples were found positive for the presence of *Blastocystis* sp. This demonstrates the higher sensitivity of this molecular test and calls the attention to the frequency of the possibility of false negative results when using techniques such as direct stool examination and concentration with formaldehyde ethyl acetate for the diagnosis of this parasite. This issue has been corroborated by previous reports, indicating that studies on *Blastocystis* sp. prevalence that rely on microscopy of fecal samples are probably underestimating the true frequency of this infection ([@bb0150]; [@bb0265]). In this sense, the reported *Blastocystis* sp. prevalence of 38.9% obtained in a previous study on intestinal parasitism in Panama ([@bb0225]), although by itself high, could be below the actual frequency considering that only one flotation concentration technique was used.

The results of the questionnaire carried out in the 37 homes from which the children evaluated came noted that having diarrhea recently was significantly related to *Blastocystis* sp. infection in this study ([Fig. 2](#f0010){ref-type="fig"}). No other risk factors evaluated were statistically associated with *Blastocystis* sp. infection. Previous studies indicate that age is a risk factor associated with *Blastocystis* infection ([@bb0155]; [@bb0090]; [@bb0190]). However, it should be considered that the statistical power of our analysis may be affected by the low number of evaluated samples and the high prevalence of *Blastocystis* sp. infections. Regarding age as a risk factor, it is also will be important to assess the prevalence of infection among adults who live with children, especially considering that the presence of an infected family member may contribute to the transmission of *Blastocystis* sp. among other family members ([@bb0155]).

Our results suggest a high prevalence of *Blastocystis* sp. infection together with a low frequency of other intestinal parasites is a finding that should be considered uncommon for this type of rural population ([@bb0285]; [@bb0065]; [@bb0070]). In this regard, it is important to consider the recent administration of antiparasitic drugs, but without action against *Blastocystis* sp. Because two months before starting the present study, students from the primary school of Las Pavas received a single dose of albendazole. This treatment is usually done once a year without previous diagnoses, as part of a joint program between the Ministries of Education and Health of Panama. It is known that this drug is efficient against the most frequent intestinal helminthiases and giardiasis ([@bb0240]), but is not a recognized drug for the treatment of blastocystosis ([@bb0105]). However, the effects of this antiparasitic drug, regarding *Blastocystis* sp. infection, are difficult to conclude based on the evaluated data. Thus, it is advisable that these deworming programs be carried out after performing the corresponding coproparasitological studies of all children ([@bb0280]). With these results, a better selection of the drugs to be used can be achieved; that in the case of infection with *Blastocystis* sp., metronidazole could be a better choice ([@bb0210]).

At least ten (ST1-ST9 and ST12) of the 17 described subtypes of *Blastocystis* sp. have been reported in humans, the rest have only been demonstrated so far in animal feces ([@bb0245]; [@bb0300]). Despite the large number of studies, the association of these subtypes with a certain clinical characteristic remains unclear ([@bb0075]; [@bb0095]; [@bb0275]). In the present study, it was possible to determine the subtype in 49 *Blastocystis* sp. positive samples. Twenty-eight samples were assigned to ST1 and 21 to ST3, being the first report on the genetic diversity of *Blastocystis* sp. in Panama. Unfortunately, with the methodology used by us, mixed subtype infections may not be evident in sequence chromatograms and can thus be undetected ([@bb0245]). In this regard, we must also emphasize that the presence of mixed subtype infections is an important characteristic, in order to explore the diversity and distribution of this parasite in the human gut ([@bb0230]). In addition, given the small number of samples evaluated, it is very likely that other subtypes could also be circulating in this or other geographic regions of the country. It has been reported that ST1 and ST3 infects a wide variety of domestic animal species including cattle, pigs and dogs and that therefore may be related to zoonotic transmission ([@bb0010]; [@bb0170]; [@bb0255]). As observed in our study, ST1 was the most common subtype found in some rural communities in Colombia ([@bb0205]; [@bb0220]). Although ST3 has been considered the most frequent subtype that infects humans worldwide ([@bb0145]; [@bb0055]), ST1 showed a higher prevalence in the child population studied. Some studies suggest that ST3 is more associated with disease than ST1 ([@bb0035]; [@bb0235]), however both subtypes are frequent in people without symptoms ([@bb0310]; [@bb0110]; [@bb0180]; [@bb0205]). In this sense, none of the children evaluated in this study reported gastrointestinal symptoms on the day of the stool collection. On the other hand, the zoonotic potential of *Blastocystis* sp. has been described in several reports ([@bb0185]; [@bb0045]). Both ST1 and ST3 have been found in cattle feces ([@bb0010]; [@bb0015]; [@bb0045]). This should be considered when establishing epidemiological measures to prevent blastocystosis in this community, since there is a private farm with many animals, including cows, in areas near the main facilities of the aqueduct that supplies water to the community. The presence of *Blastocystis* sp. in water for human consumption has been confirmed in several studies ([@bb0140]; [@bb0025]; [@bb0005]). Unfortunately, the water distributed through the aqueduct of Las Pavas does not receive any type of treatment. Thus, the evaluation of the presence or not of *Blastocystis* sp. and other enteropathogens in water for human consumption and in farm animal feces from this community is an important pending task.

Finally, it is important to remind the health personnel of this region that a high frequency of apparently *Blastocystis* sp. asymptomatic cases should not be an excuse for not providing the corresponding clinical care to these patients and organizing basic preventive measures for this infection.

5. Conclusions {#s0055}
==============

The results indicate a high prevalence of infection with *Blastocystis* sp. in the studied child population, even with a low frequency of other intestinal parasites. Also, they confirm the added value of using molecular diagnostic methods for this parasitic infection. Additionally, it provides the first genetic characterization of *Blastocystis* sp. subtypes circulating in a rural area of Panama. Infections in this child population with subtypes ST1 and ST3 were demonstrated, with a slight predominance of ST1. Finally, the study highlights the need to investigate the clinical pictures of *Blastocystis* sp. infections, to establish educational interventions and to evaluate the presence of *Blastocystis* sp. in water sources, as well as the role of domestic and farm animals in the transmission of this parasite in this community.
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